Literature DB >> 16036490

Effects of allopurinol, a xanthine oxidase inhibitor, on renal injury in hypercholesterolemia-induced hypertensive rats.

Mayumi Minami1, Akihiro Ishiyama, Masao Takagi, Masao Omata, Keiichiro Atarashi.   

Abstract

To investigate if increased lipid peroxidation is involved in hypercholesterolemia-induced hypertension and renal injury, we examined the effects of allopurinol, a xanthine oxidase inhibitor, on these conditions. Groups of male Sprague--Dawley rats were fed for 8 weeks with a high-cholesterol diet (4% cholesterol), a high-cholesterol plus allopurinol (10 mg/kgBW/day) diet or a normal diet. Systolic blood pressure (SBP), serum lipids, uric acid (UA) and malondialdehyde (MDA) as a measure of lipid peroxides, and urinary excretion of protein (UP) were measured after 0, 4 and 8 weeks. Urinary excretion of nitrite plus nitrate (UNOx) and iron (UFe), and MDA in the kidney were measured after 8 weeks. The renal injury was evaluated by the glomerular sclerosis score (SS). The high-cholesterol diet increased SBP, serum total cholesterol and UA, MDA in the serum and kidney, UP, UNOx, UFe and SS. Allopurinol ameliorated cholesterol-induced elevation in serum UA, MDA in the serum and kidney, UP, UNOx, UFe and SS, but did not affect SBP. Hence, our results suggest that lipid peroxidation may be involved in hypercholesterolemia-induced renal injury, and that suppression of lipid peroxidation can reduce such injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16036490     DOI: 10.1080/08037050510008878

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  9 in total

1.  Vitamin E and regression of hypercholesterolemia-induced oxidative stress in kidney.

Authors:  Kailash Prasad
Journal:  Mol Cell Biochem       Date:  2013-09-21       Impact factor: 3.396

2.  Vitamin E slows the progression of hypercholesterolemia-induced oxidative stress in heart, liver and kidney.

Authors:  Kailash Prasad; Erick D McNair; A Mabood Qureshi; Gudrun Casper-Bell
Journal:  Mol Cell Biochem       Date:  2012-06-20       Impact factor: 3.396

3.  Allopurinol does not decrease blood pressure or prevent the development of hypertension in the deoxycorticosterone acetate-salt rat model.

Authors:  Theodora Szasz; A Elizabeth Linder; Robert P Davis; Robert Burnett; Gregory D Fink; Stephanie W Watts
Journal:  J Cardiovasc Pharmacol       Date:  2010-12       Impact factor: 3.105

4.  Isoorientin exerts a urate-lowering effect through inhibition of xanthine oxidase and regulation of the TLR4-NLRP3 inflammasome signaling pathway.

Authors:  Meng-Fei An; Ming-Yue Wang; Chang Shen; Ze-Rui Sun; Yun-Li Zhao; Xuan-Jun Wang; Jun Sheng
Journal:  J Nat Med       Date:  2020-11-13       Impact factor: 2.343

5.  Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation.

Authors:  Chuang Wang; Ying Pan; Qing-Yu Zhang; Fu-Meng Wang; Ling-Dong Kong
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

6.  Effects of Uric Acid on Lipid Levels in CKD Patients in a Randomized Controlled Trial.

Authors:  Rodney G Bowden; Brian D Shelmadine; Jennifer J Moreillon; Erika Deike; Jackson O Griggs; Ronald L Wilson
Journal:  Cardiol Res       Date:  2013-05-09

7.  Effects of Urate-Lowering Therapy on Risk of Hyperlipidemia in Gout by a Population-Based Cohort Study and on In Vitro Hepatic Lipogenesis-Related Gene Expression.

Authors:  Yi-Jen Fang; Tien-Yuan Wu; Cheng-Li Lin; Chih-Yang Su; Jia-Rong Li; Yun-Lung Chung; Ni Tien; Yun-Ping Lim
Journal:  Mediators Inflamm       Date:  2020-11-14       Impact factor: 4.711

8.  Association between baseline serum uric acid and development of LDL-C level in patients with first acute myocardial infarction.

Authors:  Yang Chen; Congcong Ding; Longlong Hu; Yuehua Ruan; Kai Zou; Cong Dai; Yanhui Liao; Hanhui Liao; Yi Xia; Yuanbin Zhao; Renqiang Yang
Journal:  BMC Cardiovasc Disord       Date:  2021-11-30       Impact factor: 2.298

9.  Long-term inhibition of xanthine oxidase by febuxostat does not decrease blood pressure in deoxycorticosterone acetate (DOCA)-salt hypertensive rats.

Authors:  Theodora Szasz; Robert Patrick Davis; Hannah S Garver; Robert J Burnett; Gregory D Fink; Stephanie W Watts
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.